Clover Health Investments Corp. Cl A (CLOV) News

Clover Health Investments Corp. Cl A (CLOV): $0.88

0.04 (+4.23%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add CLOV to Watchlist
Sign Up

Industry: Medical - Health Insurance

Industry

A

Ranked

#10 of 11

in industry

Filter CLOV News Items

CLOV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CLOV News Highlights

  • For CLOV, its 30 day story count is now at 2.
  • Over the past 1 day, the trend for CLOV's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about CLOV are RYAN.

Latest CLOV News From Around the Web

Below are the latest news stories about CLOVER HEALTH INVESTMENTS CORP that investors may wish to consider to help them evaluate CLOV as an investment opportunity.

7 Overvalued Penny Stocks to Sell Before June 2023

Taking this into account, if you own any of these seven overvalued penny stocks to sell, consider it high time to make your exit.

Thomas Niel on InvestorPlace | May 28, 2023

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call Transcript May 9, 2023 Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health First Quarter 2023 Earnings Conference Call. As a reminder, today’s call is being recorded. I would now like to turn the call over to Ryan Schmidt, Investor Relations for Clover […]

Yahoo | May 10, 2023

Clover Health Reports First Quarter 2023 Financial Results

Insurance revenue grew by 14% over Q1’22 Insurance and Non-Insurance MCR improved to 86.6% and 96.1%, respectively Improved 2023 guidance includes Insurance MCR of 87% - 89%, Insurance revenue of $1.18 billion - $1.23 billion, and Adjusted EBITDA of ($125) million - ($175) million FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healt

Yahoo | May 9, 2023

Chamath Palihapitiya’s Crumbling SPAC Empire: Where His Top 5 Deals Are Today

None of the companies the King of SPACs Chamath Palihaitiya took public has made money for investors, although one still has a chance.

Dana Blankenhorn on InvestorPlace | May 5, 2023

Clover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023

FRANKLIN, Tenn., May 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at the Bank of America 2023 Healthcare Conference on Thursday, May 11, 2023, at 1:40 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https

Yahoo | May 4, 2023

Clover Health Announces Agreement to Settle Securities Class Action Litigation

FRANKLIN, Tenn., April 24, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement to resolve the securities class action captioned Bond v. Clover Health Investments, Corp. et al., Case No. 3:21-CV-00096 (M.D. Tenn.) (the “securities class action”), which was filed in the w

Yahoo | April 24, 2023

Clover Health Announces Business Transformation Initiatives to Accelerate Path to Profitability

Net annualized savings from initiatives expected to be approximately $30 million beginning in 2024 FRANKLIN, Tenn., April 17, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health” or “the company”), today announced business transformation initiatives to accelerate the company’s path to profitability, including an agreement to move its core plan operations to UST HealthProof’s integrated technology platform and additional corporate restructuring act

Yahoo | April 17, 2023

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late

You have to be patient when investing in pharma stocks.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | April 16, 2023

Clover Health to Report First Quarter 2023 Financial Results on May 9, 2023

FRANKLIN, Tenn., April 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report first quarter 2023 financial results after market close on Tuesday, May 9, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s business and finan

Yahoo | April 11, 2023

3 SPACs to Sell Before They Go Bust in 2023

Traders are looking for bargains amid busted SPAC stocks.

Ian Bezek on InvestorPlace | March 24, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7262 seconds.